Phase II Study of Nivolumab in Combination With Radiation Therapy as Definitive Treatment for Patients With Locally Advanced, Unresectable Head and Neck Mucosal Melanoma.
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Neoadjuvant PD-1 Blockade in Patients with Stage IIB/C Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Dabrafenib/Trametinib/Hydroxychloroquine for Advanced Pretreated BRAF V600 Mutant Melanoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Intralesional Sclerosant for in Transit and Cutaneous Melanoma Metastases
- Status
- WITHDRAWN
- Phase
- PHASE2
Intratumoral Injection of Autologous CD1c (BDCA-1)+ Myeloid Dendritic Cells Plus Talimogene Laherparepvec (T-VEC)
- Status
- UNKNOWN
- Phase
- PHASE1
SunSmart Intervention in Schools
- Status
- COMPLETED
- Phase
- NA
Nivolumab, BMS-936558 in Combination with Relatlimab, BMS-986016 in Patients with Metastatic Melanoma Naïve to Prior Immunotherapy in the Metastatic Setting
- Status
- COMPLETED
- Phase
- PHASE2
18FDG-PET in Patients With Melanoma or NSCLC Treated With Immunotherapy
- Status
- COMPLETED
- Phase
- N/A
A Comparison of Nivolumab-based Treatments in a Real-world PD-L1 Positive Metastatic Melanoma Population in the US
- Status
- COMPLETED
- Phase
- N/A
MGC018 With or Without MGA012 in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Melanoma
- Status
- TERMINATED
- Phase
- N/A
Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for Melanoma
- Status
- COMPLETED
- Phase
- NA
Study to Evaluate the Safety of Pembrolizumab in Participants With Unresectable or Metastatic Melanoma or Non-small Cell Lung Cancer in India (MK-3475-593/KEYNOTE-593)
- Status
- COMPLETED
- Phase
- PHASE4
PVSRIPO for Patients With Unresectable Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
A Study of IMM-101 in Combination With Checkpoint Inhibitor Therapy in Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Novel Mechanisms and Predictors of VEGF Receptor Inhibitor- or Immune Checkpoint Inhibitor-Associated Hypertension and Cardiovascular Disease
- Status
- TERMINATED
- Phase
- N/A
Liquid Biopsy Evaluation and Repository Development at Princess Margaret
- Status
- RECRUITING
- Phase
- N/A
A Study is to Understand the Treatment Patterns for Immunotherapy Agents and BRAF/MEK Inhibitors Used in the Treatment of Advanced Melanoma
- Status
- COMPLETED
- Phase
- N/A
Evaluating the Effect of Nivolumab for Patients With In-transit Metastases Treated With Isolated Limb Perfusion
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2